Related Experiment Video
Updated: Apr 30, 2026

09:37
A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
7.7K
Ketogenic diet alters dopaminergic activity in the mouse cortex
William H Church1, Ryan E Adams1, Livia S Wyss1
1Department of Chemistry and Neuroscience Program, Trinity College, Hartford, CT, USA.
Neuroscience Letters
|April 29, 2014
Summary
The ketogenic diet increased dopaminergic activity in mouse brain regions, specifically the motor and somatosensory cortex. This change in dopamine (DA) neurotransmission may explain the diet's effectiveness in reducing epileptic seizures.
Area of Science:
- Neuroscience
- Dietary Science
- Biochemistry
Background:
- The ketogenic diet is a high-fat, low-carbohydrate diet.
- It is recognized for its efficacy in managing drug-resistant epilepsy.
- The underlying neurobiological mechanisms are not fully understood.
Purpose of the Study:
- To investigate the impact of a 3-week ketogenic diet on basal monoamine neurotransmitter levels in specific mouse brain regions.
- To assess alterations in dopamine (DA), norepinephrine (NE), and serotonin (5HT) and their metabolites.
Main Methods:
- Adult mice were fed a ketogenic diet for 3 weeks.
- Postmortem quantification of neurotransmitters (DA, NE, 5HT) and metabolites (DOPAC, HVA, 5HIAA) in six brain regions.
- Analysis of dopaminergic activity using the ([DOPAC]+[HVA])/[DA] ratio.
Main Results:
- A significant increase in dopaminergic activity was observed in the motor cortex and somatosensory cortex of mice on the ketogenic diet compared to controls.
- No significant changes were noted in other brain regions examined.
- Serotonin and norepinephrine levels and their metabolites did not show significant alterations.
Conclusions:
- The ketogenic diet modulates dopaminergic activity within the meso-cortical pathways.
- These neurochemical alterations may be a key factor in the ketogenic diet's anticonvulsant effects.
- Further research is warranted to elucidate the precise role of dopaminergic changes in ketogenic diet therapy for epilepsy.

